CA2234824A1 - Treatment of traumatic brain injury - Google Patents
Treatment of traumatic brain injury Download PDFInfo
- Publication number
- CA2234824A1 CA2234824A1 CA002234824A CA2234824A CA2234824A1 CA 2234824 A1 CA2234824 A1 CA 2234824A1 CA 002234824 A CA002234824 A CA 002234824A CA 2234824 A CA2234824 A CA 2234824A CA 2234824 A1 CA2234824 A1 CA 2234824A1
- Authority
- CA
- Canada
- Prior art keywords
- treatment
- ethyl
- tetrazol
- traumatic brain
- brain injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK1232/95 | 1995-11-06 | ||
DK123295 | 1995-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2234824A1 true CA2234824A1 (en) | 1997-05-15 |
Family
ID=8102484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002234824A Abandoned CA2234824A1 (en) | 1995-11-06 | 1996-11-05 | Treatment of traumatic brain injury |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0866706A1 (pt) |
JP (1) | JPH11514654A (pt) |
KR (1) | KR19990067353A (pt) |
AU (1) | AU706594B2 (pt) |
BG (1) | BG63150B1 (pt) |
BR (1) | BR9611396A (pt) |
CA (1) | CA2234824A1 (pt) |
CZ (1) | CZ287441B6 (pt) |
EA (1) | EA000531B1 (pt) |
HU (1) | HUP9901051A2 (pt) |
IS (1) | IS4726A (pt) |
NO (1) | NO982036L (pt) |
NZ (1) | NZ321546A (pt) |
PL (1) | PL326490A1 (pt) |
SK (1) | SK58198A3 (pt) |
TR (1) | TR199800801T2 (pt) |
WO (1) | WO1997017074A1 (pt) |
ZA (1) | ZA969320B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013096A1 (es) * | 1997-07-01 | 2000-12-13 | Lundbeck & Co As H | Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma. |
EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
WO2007025177A2 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
US5328925A (en) * | 1989-02-22 | 1994-07-12 | Novo Nordisk A/S | Piperidine compounds and their use |
IE922270A1 (en) * | 1991-07-26 | 1993-01-27 | Akzo Nv | Pyrazole derivatives |
US5330994A (en) * | 1992-03-24 | 1994-07-19 | Warner-Lambert Company | Tetrahydropyridine isoxazoline derivatives |
-
1996
- 1996-11-05 CA CA002234824A patent/CA2234824A1/en not_active Abandoned
- 1996-11-05 BR BR9611396A patent/BR9611396A/pt not_active Application Discontinuation
- 1996-11-05 JP JP9517762A patent/JPH11514654A/ja active Pending
- 1996-11-05 NZ NZ321546A patent/NZ321546A/xx unknown
- 1996-11-05 EA EA199800434A patent/EA000531B1/ru not_active IP Right Cessation
- 1996-11-05 TR TR1998/00801T patent/TR199800801T2/xx unknown
- 1996-11-05 AU AU74900/96A patent/AU706594B2/en not_active Ceased
- 1996-11-05 WO PCT/DK1996/000458 patent/WO1997017074A1/en not_active Application Discontinuation
- 1996-11-05 HU HU9901051A patent/HUP9901051A2/hu unknown
- 1996-11-05 EP EP96937193A patent/EP0866706A1/en not_active Ceased
- 1996-11-05 CZ CZ19981389A patent/CZ287441B6/cs not_active IP Right Cessation
- 1996-11-05 SK SK581-98A patent/SK58198A3/sk unknown
- 1996-11-05 PL PL96326490A patent/PL326490A1/xx unknown
- 1996-11-05 KR KR1019980703360A patent/KR19990067353A/ko not_active Application Discontinuation
- 1996-11-06 ZA ZA969320A patent/ZA969320B/xx unknown
-
1998
- 1998-04-27 IS IS4726A patent/IS4726A/is unknown
- 1998-05-05 NO NO982036A patent/NO982036L/no not_active Application Discontinuation
- 1998-05-22 BG BG102480A patent/BG63150B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
BG63150B1 (bg) | 2001-05-31 |
AU7490096A (en) | 1997-05-29 |
AU706594B2 (en) | 1999-06-17 |
NO982036L (no) | 1998-06-25 |
MX9803432A (es) | 1998-09-30 |
WO1997017074A1 (en) | 1997-05-15 |
BG102480A (en) | 1999-01-29 |
HUP9901051A2 (hu) | 2000-03-28 |
SK58198A3 (en) | 1998-10-07 |
PL326490A1 (en) | 1998-09-28 |
ZA969320B (en) | 1997-05-30 |
CZ138998A3 (cs) | 1998-10-14 |
EP0866706A1 (en) | 1998-09-30 |
KR19990067353A (ko) | 1999-08-16 |
JPH11514654A (ja) | 1999-12-14 |
NO982036D0 (no) | 1998-05-05 |
BR9611396A (pt) | 1999-07-13 |
EA199800434A1 (ru) | 1998-10-29 |
TR199800801T2 (xx) | 1998-08-21 |
CZ287441B6 (en) | 2000-11-15 |
IS4726A (is) | 1998-04-27 |
EA000531B1 (ru) | 1999-10-28 |
NZ321546A (en) | 2000-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60211937T2 (de) | Verwendung von flibanserin bei der behandung von störungen des sexuellen verlangens | |
DE3650733T2 (de) | Pharmazeutische Zubereitungen und medizinische Verwendungen von Dioxopiperidinderivaten, insbesondere als Verstärker der Immunantwort sowie als antivirale und antibakterielle Wirkstoffe | |
EP0651642A1 (en) | Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity | |
EP0615751B1 (en) | Use of tachykinin antagonists in the treatment of emesis | |
JPH10508866A (ja) | オンダンセトロンを含有する経口組成物 | |
US5290783A (en) | Use of spiperone derivatives as immunosuppressant agents | |
US6297262B1 (en) | Treatment of schizophrenia and psychosis | |
US4835173A (en) | Method of medical treatment | |
AU706594B2 (en) | Treatment of traumatic brain injury | |
EP0275668B1 (en) | Use of ketone derivatives in the treatment of cognitive disorders | |
KR950010148B1 (ko) | 중독증 치료용 의약품 | |
AU764304B2 (en) | Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of major depressive disorders | |
US20060135507A1 (en) | Therapeutic agent for overactive bladder involved in aging | |
US20060269598A1 (en) | Antihistaminic/Decongestant/Anticholinergic Compositions and Methods of Use | |
JP2005532274A (ja) | 雄避妊のための非ホルモン的アプローチ | |
US20060269597A1 (en) | Tannate Compositions and Methods of Use for the Treatment of Respiratory Tract Conditions | |
EP0690715B1 (en) | Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses | |
CA2022379A1 (en) | Medicaments | |
MXPA98003432A (en) | Treatment of traumat cerebral damage | |
US20030166667A1 (en) | Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient | |
JPH01250319A (ja) | 医薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |